Strides Pharma Science Ltd - Share Price

STAR

Open

469.80

Prev. Close

463.55

Turnover (lac.)

7,173

Day's High

469.80

Day's Low

461.70

52 Week's High

999.00

52 Week's Low

460.70

Book Value

361

Face Value

10

Mkt Cap (Cr.)

4,183

P/E

63.56

EPS

7.33

Divi. Yield

0.54

Strides Pharma Science LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Strides Pharma Science LtdNews & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd757.55101.82181,761.62809.070.994,120.93113.47
Divis Laboratories Ltd4,604.9558.02122,272.17606.390.431,967.86372.89
Dr Reddys Laboratories Ltd4,570.7047.0276,064.83449.000.553,809.501,049.73
Cipla Ltd897.9526.9672,441.39782.370.563,858.82261.90
Piramal Enterprises Ltd2,627.15245.0862,762.5934.341.19515.35962.90

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Strides Pharma Science LtdSummary & Reports

Strides Pharma Science Limited is an integrated manufacturer and exporter of finished pharmaceutical dosage forms for both branded and generic. The company manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals. Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semi-solids. They undertake contract research and manufacturing of specialty chemicals. ... More

Registered Office

No 201 Devavrata Sector 17,Vashi,Navi Mumbai, Maharashtra,400703

Tell. : +91-22-27892924/27893199
Website : http://www.stridesarco.com
Email : investors@stridesshasun.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com

Latest Release by strides-pharma-science-ltd-share-price

View

- <

Reco. Price

Nov 23,2021 01:05 PM

Target Price

Target Returns:

0.00%

Result Express

Strides Arcolab Ltd's Q3FY19 consolidated net profit declines 38.09% yoy to Rs30.83cr : In-line with Estimates

Dec 09, 2021 04:28 AM

The company’s consolidated revenue stood at Rs794.50cr, up 6.07% yoy and 8.44% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    10 Nov 2021

    Annc. Date

    03 Nov 2021

    Quarterly ResultsWe are pleased to enclose the Unaudited Financial Results (Standalone and Consolida... More

  • Purpose

    AGM

    Exp. Date

    03 Sep 2021

    Annc. Date

    26 Jul 2021

    We wish to inform you that 30th Annual General Meeting (AGM) of the Company will be held over video ... More

  • Purpose

    Board Meeting

    Exp. Date

    06 Aug 2021

    Annc. Date

    29 Jul 2021

    Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company... More